Citi Pharma and CCL Pharma execute agreement to manufacture Formulation Products

By MG News | July 14, 2021 at 03:22 PM GMT+05:00

0:00

July 14, 2021 (MLN): Citi Pharma Limited (CPHL) and CCL Pharma (Pvt) Limited have executed an agreement to manufacture Formulation Products on their behalf

In a notification to PSX, CPHL informed that this will lead to enhance capacity utilization on the Company’s Formulation segment. Furthermore, this will lead to the addition in Company’s profitability and net margins over the next 2 to 3 years.

Copyright Mettis Link News

Related News

Image Pakistan plans acquisition of UK luxury brand

Lucky Cement, partners explore PIA acquisition

Fertilizer profits set to bloom 17% YoY, EFERT, FFC likely to announce Rs4 & Rs11.5 dividends

Name	Price/Vol	%Chg/NChg
KSE100	132,758.61 122.24M	-0.48% -644.58
ALLSHR	83,090.60 696.72M	-0.12% -97.45
KSE30	40,404.71 44.37M	-0.61% -246.75
KMI30	191,125.60 51.51M	-0.50% -958.32
KMIALLSHR	55,793.57 348.56M	-0.10% -54.13
BKTi	36,219.23 7.85M	-0.56% -203.65
OGTi	28,366.49 8.86M	-0.25% -71.12

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	109,195.00	109,545.00 108,625.00	-20.00 -0.02%
BRENT CRUDE	70.65	70.71 69.85	0.50 0.71%
RICHARDS BAY COAL MONTHLY	97.50	0.00 0.00	2.05 2.15%
ROTTERDAM COAL MONTHLY	106.65	106.65 106.25	0.50 0.47%
USD RBD PALM OLEIN	998.50	998.50 998.50	0.00 0.00%
CRUDE OIL - WTI	68.86	68.94 67.78	0.53 0.78%
SUGAR #11 WORLD	16.31	16.32 16.08	0.18 1.12%